FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100040723> ?p ?o ?g. }

• W2100040723 endingPage "336" @default.
• W2100040723 startingPage "322" @default.
• W2100040723 abstract "Benzodiazepines are treatment mainstays for several disorders, but there is often concern about dependency and addiction. In January 1989, New York implemented regulations requiring physicians to order benzodiazepines using state-monitored triplicate prescription forms.The purpose of this study was to assess the effects of the triplicate prescription program (TPP) on changes in use of benzodiazepines and other psychoactive drugs in clinically vulnerable Medicaid populations.Using an interrupted time series with comparison series design, psychoactive medication use was examined in the New York (intervention) and New Jersey (control) Medicaid programs before and after implementation of the New York benzodiazepine TPP among community-dwelling Medicaid beneficiaries aged >/=19 years continuously enrolled from January 1988 through December 1990 in New York or New Jersey with diagnoses of schizophrenia, schizophreniform disorder, schizoaffective disorder, schizoid personality disorder, or schizotypal personality disorder; bipolar disorder; epilepsy; and/or panic disorder, agoraphobia without history of panic disorder, social phobia, or specific phobia.A total of 125,837 New York and 139,405 New Jersey Medicaid beneficiaries were continuously enrolled and met the study inclusion criteria. Of these, there were 6054 Medicaid enrollees in New York and 6875 enrollees in New Jersey who were clinically vulnerable patients with >/=1 of the specified diagnoses. New York Medicaid patients with any of these diagnoses experienced a -48.1% relative change (95% CI, -50.0% to -46.2%) in benzodiazepine use at 6 months after TPP implementation, with no decline in use in New Jersey patients. The largest reduction in benzodiazepine use was seen among patients with seizure disorder (-59.9% at 6 months; 95% CI, -63.9% to -55.9%). Although use of substitute drugs increased slightly in New York after the TPP, it did not offset reductions in benzodiazepine use. The effects of TPP were sustained for 7 years of follow-up and had the greatest impact on nonproblematic benzodiazepine use.During the time period studied in this analysis, the New York TPP reduced benzodiazepine use among chronically ill patients for whom these agents represent effective treatment. Our findings suggest that many patients previously receiving benzodiazepines did not receive any pharmacologic intervention." @default.
• W2100040723 created "2016-06-24" @default.
• W2100040723 creator A5008667779 @default.
• W2100040723 creator A5011425931 @default.
• W2100040723 creator A5029844807 @default.
• W2100040723 creator A5030151797 @default.
• W2100040723 creator A5066278367 @default.
• W2100040723 creator A5067489486 @default.
• W2100040723 creator A5074451946 @default.
• W2100040723 creator A5077719091 @default.
• W2100040723 creator A5077939313 @default.
• W2100040723 creator A5087952822 @default.
• W2100040723 date "2004-02-01" @default.
• W2100040723 modified "2023-10-16" @default.
• W2100040723 title "A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders" @default.
• W2100040723 cites W1518214111 @default.
• W2100040723 cites W154086589 @default.
• W2100040723 cites W1964040308 @default.
• W2100040723 cites W1981107088 @default.
• W2100040723 cites W1992469328 @default.
• W2100040723 cites W1998754678 @default.
• W2100040723 cites W2001956495 @default.
• W2100040723 cites W2002134525 @default.
• W2100040723 cites W2006697438 @default.
• W2100040723 cites W2008247769 @default.
• W2100040723 cites W2017903824 @default.
• W2100040723 cites W2022940976 @default.
• W2100040723 cites W2037286223 @default.
• W2100040723 cites W2047890949 @default.
• W2100040723 cites W2059198188 @default.
• W2100040723 cites W2070225299 @default.
• W2100040723 cites W2114836807 @default.
• W2100040723 cites W2146329326 @default.
• W2100040723 cites W2320419323 @default.
• W2100040723 cites W2324278286 @default.
• W2100040723 cites W2335564749 @default.
• W2100040723 cites W2335780156 @default.
• W2100040723 cites W2339692629 @default.
• W2100040723 cites W2414522344 @default.
• W2100040723 cites W4234874919 @default.
• W2100040723 cites W4254537995 @default.
• W2100040723 cites W81453398 @default.
• W2100040723 doi "https://doi.org/10.1016/s0149-2918(04)90030-6" @default.
• W2100040723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15038954" @default.
• W2100040723 hasPublicationYear "2004" @default.
• W2100040723 type Work @default.
• W2100040723 sameAs 2100040723 @default.
• W2100040723 citedByCount "42" @default.
• W2100040723 countsByYear W21000407232012 @default.
• W2100040723 countsByYear W21000407232013 @default.
• W2100040723 countsByYear W21000407232014 @default.
• W2100040723 countsByYear W21000407232015 @default.
• W2100040723 countsByYear W21000407232016 @default.
• W2100040723 countsByYear W21000407232019 @default.
• W2100040723 countsByYear W21000407232021 @default.
• W2100040723 countsByYear W21000407232022 @default.
• W2100040723 countsByYear W21000407232023 @default.
• W2100040723 crossrefType "journal-article" @default.
• W2100040723 hasAuthorship W2100040723A5008667779 @default.
• W2100040723 hasAuthorship W2100040723A5011425931 @default.
• W2100040723 hasAuthorship W2100040723A5029844807 @default.
• W2100040723 hasAuthorship W2100040723A5030151797 @default.
• W2100040723 hasAuthorship W2100040723A5066278367 @default.
• W2100040723 hasAuthorship W2100040723A5067489486 @default.
• W2100040723 hasAuthorship W2100040723A5074451946 @default.
• W2100040723 hasAuthorship W2100040723A5077719091 @default.
• W2100040723 hasAuthorship W2100040723A5077939313 @default.
• W2100040723 hasAuthorship W2100040723A5087952822 @default.
• W2100040723 hasConcept C118552586 @default.
• W2100040723 hasConcept C15744967 @default.
• W2100040723 hasConcept C160735492 @default.
• W2100040723 hasConcept C162324750 @default.
• W2100040723 hasConcept C169900460 @default.
• W2100040723 hasConcept C187288502 @default.
• W2100040723 hasConcept C2426938 @default.
• W2100040723 hasConcept C2776174506 @default.
• W2100040723 hasConcept C2776412080 @default.
• W2100040723 hasConcept C2776534028 @default.
• W2100040723 hasConcept C2777308609 @default.
• W2100040723 hasConcept C2777529043 @default.
• W2100040723 hasConcept C2779437044 @default.
• W2100040723 hasConcept C2779727114 @default.
• W2100040723 hasConcept C2780325297 @default.
• W2100040723 hasConcept C50522688 @default.
• W2100040723 hasConcept C558461103 @default.
• W2100040723 hasConcept C71924100 @default.
• W2100040723 hasConcept C77805123 @default.
• W2100040723 hasConcept C98274493 @default.
• W2100040723 hasConceptScore W2100040723C118552586 @default.
• W2100040723 hasConceptScore W2100040723C15744967 @default.
• W2100040723 hasConceptScore W2100040723C160735492 @default.
• W2100040723 hasConceptScore W2100040723C162324750 @default.
• W2100040723 hasConceptScore W2100040723C169900460 @default.
• W2100040723 hasConceptScore W2100040723C187288502 @default.
• W2100040723 hasConceptScore W2100040723C2426938 @default.
• W2100040723 hasConceptScore W2100040723C2776174506 @default.
• W2100040723 hasConceptScore W2100040723C2776412080 @default.
• W2100040723 hasConceptScore W2100040723C2776534028 @default.

• next